LONIGUTAMAB

UNII:	56GN9PT35D
Formula:
Preferred Substance Name:	LONIGUTAMAB
GSRS Full Record:	56GN9PT35D i

2362015-67-4
IMMUNOGLOBULIN G1 (DE-C-TERMINAL-LYSINE), ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL HZ208F2-4 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HZ208F2-4 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IGF1R (INSULIN LIKE GROWTH FACTOR 1 RECEPTOR, IGF1-R, IGF-1R, CD221)), HUMANIZED MONOCLONAL ANTIBODY
LONIGUTAMAB [INN]
VB421
VB-421

Common Chemistry
i
Inxight Drugs
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LONIGUTAMAB

Synonyms and Mappings

Resources